Crinetics Pharmaceuticals (CRNX) Other Working Capital Changes (2017 - 2026)

Crinetics Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$685000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 89.75% year-over-year to -$685000.0; the TTM figure through Mar 2026 stood at -$1.0 million (changed N/A YoY), while the FY2025 annual figure was -$1.8 million, down 2579.73% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$685000.0, down from $743000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $20.3 million in Q3 2025, with the low at -$10.3 million in Q3 2023.
• The 5-year median for Other Working Capital Changes is $476000.0 (2022), against an average of $2.0 million.
• The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes surged 200.81% in 2025, then tumbled 89.75% in 2026.
• Crinetics Pharmaceuticals' Other Working Capital Changes stood at -$737000.0 in 2024, then soared by 200.81% to $743000.0 in 2025, then plunged by 192.19% to -$685000.0 in 2026.
• Business Quant data shows CRNX's Other Working Capital Changes at -$685000.0 in Q1 2026, $743000.0 in Q4 2025, and -$361000.0 in Q1 2025.